American Trust Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $222K | Buy |
3,855
+162
| +4% | +$9.3K | 0.11% | 78 |
|
|
2026
Q1 | $224K | Buy |
+3,693
| New | +$215K | 0.12% | 74 |
|
|
2025
Q3 | – | Sell |
-5,109
| Closed | -$236K | – | 86 |
|
|
2025
Q2 | $236K | Sell |
5,109
-13,689
| -73% | -$672K | 0.12% | 78 |
|
|
2025
Q1 | $1.15M | Buy |
18,798
+602
| +3% | +$35.1K | 0.48% | 43 |
|
|
2024
Q4 | $1.03M | Sell |
18,196
-95
| -0.5% | -$5.31K | 0.42% | 43 |
|
|
2024
Q3 | $946K | Buy |
18,291
+5,175
| +39% | +$243K | 0.39% | 45 |
|
|
2024
Q2 | $545K | Buy |
13,116
+654
| +5% | +$29.3K | 0.26% | 50 |
|
|
2024
Q1 | $676K | Buy |
12,462
+701
| +6% | +$35.7K | 0.32% | 46 |
|
|
2023
Q4 | $603K | Buy |
11,761
+804
| +7% | +$42.2K | 0.31% | 47 |
|
|
2023
Q3 | $636K | Sell |
10,957
-109
| -1% | -$6.68K | 0.35% | 47 |
|
|
2023
Q2 | $708K | Buy |
11,066
+425
| +4% | +$28.5K | 0.4% | 46 |
|
|
2023
Q1 | $738K | Sell |
10,641
-19
| -0.2% | -$1.34K | 0.44% | 44 |
|
|
2022
Q4 | $767K | Buy |
10,660
+120
| +1% | +$9.05K | 0.49% | 43 |
|
|
2022
Q3 | $749K | Buy |
10,540
+82
| +0.8% | +$5.95K | 0.48% | 46 |
|
|
2022
Q2 | $805K | Buy |
10,458
+40
| +0.4% | +$3.05K | 0.5% | 46 |
|
|
2022
Q1 | $761K | Buy |
10,418
+160
| +2% | +$10.7K | 0.39% | 52 |
|
|
2021
Q4 | $640K | Buy |
10,258
+1,755
| +21% | +$103K | 0.32% | 52 |
|
|
2021
Q3 | $503K | Buy |
8,503
+210
| +3% | +$13.8K | 0.28% | 53 |
|
|
2021
Q2 | $554K | Buy |
8,293
+910
| +12% | +$59.3K | 0.3% | 51 |
|
|
2021
Q1 | $466K | Buy |
7,383
+2,995
| +68% | +$186K | 0.27% | 53 |
|
|
2020
Q4 | $272K | Buy |
+4,388
| New | +$270K | 0.17% | 65 |
|
|
2017
Q1 | – | Sell |
-3,900
| Closed | -$228K | – | 76 |
|
|
2016
Q4 | $228K | Hold |
3,900
| – | – | 0.22% | 60 |
|
|
2016
Q3 | $210K | Buy |
3,900
+820
| +27% | +$52.7K | 0.21% | 61 |
|
|
2016
Q2 | $227K | Buy |
+3,080
| New | +$218K | 0.23% | 61 |
|
|
2016
Q1 | – | Sell |
-2,950
| Closed | -$203K | – | 70 |
|
|
2015
Q4 | $203K | Buy |
+2,950
| New | +$195K | 0.23% | 66 |
|
|
2015
Q3 | – | Sell |
-3,300
| Closed | -$220K | – | 70 |
|
|
2015
Q2 | $220K | Hold |
3,300
| – | – | 0.22% | 66 |
|
|
2015
Q1 | $213K | Sell |
3,300
-315
| -9% | -$19.7K | 0.21% | 63 |
|
|
2014
Q4 | $213K | Buy |
+3,615
| New | +$204K | 0.23% | 61 |
|
Other funds holding BMY
American Trust Investment Advisors's BMY Position: Q2 2026 in Review
American Trust Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, buying an estimated $9.3K and bringing the position to 3,855 shares worth $222K. The position accounts for 0.11% of the portfolio, ranked #78.
American Trust Investment Advisors first reported a position in BMY in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.15M in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- American Trust Investment Advisors held 3,855 shares of Bristol-Myers Squibb worth $222K as of Q2 2026.
- American Trust Investment Advisors bought 162 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.3K.
- Bristol-Myers Squibb made up 0.11% of American Trust Investment Advisors's portfolio in Q2 2026, its #78 holding.
- American Trust Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 28 quarters since.
- American Trust Investment Advisors's Bristol-Myers Squibb position peaked at $1.15M in Q1 2025.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on American Trust Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.